fda label semaglutide naion warning 2025 Rybelsus Vision Loss Lawsuit [2026 Update] Semaglutide and Non-arteritic Anterior Ischemic

The emergent role of telemedicine and e-pharmacies as key stakeholders is exemplified in India, where platforms such as Tata 1mg are increasingly providing fulfilment services for rising consumer demand and concurrently facilitating the interactions between HCPs and patients

16 WenWLiHWangCChenCTangJZhouMet al

Developed by Novo Nordisk, this tablet is the first of its kind, providing an effective solution for enhancing blood sugar control alongside diet and exercise

Tirzepatide is a dual-acting medication that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors

GLP-1 receptor agonists (like semaglutide) and tirzepatide already show benefits in NAFLD/NASH